Longeveron Company
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Through patient-focused, regenerative medicine, our research and therapies are aimed at improving healthspan.
Founded Date:
2014
Last Funding Type:
Grant
Headquarters:
Miami
Investors Number:
3
Technology:
Regenerative Medicine
Employee Number:
20
Industry:
Cellular therapy
Estimated Revenue:
$1M to $10M
Number Of Exists:
11-50
Funding Status:
IPO
Investor Type:
For Profit
Total Funding:
8.99997